Suppliers / Avara Pharmaceutical Technologies

Avara Pharmaceutical Technologies

United States Updated 9 July 2026

Avara Pharmaceutical Technologies is a finished-dose manufacturer based in United States. It appears in 3 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with NPRA (MY) and UZPHARM (UZ). Its GMP standing is certified by MFDS (Korea), ANVISA (Brazil) and EAEU_EEC. Its most recent recorded inspection, by US FDA, closed on 31 October 2022 as NAI.

0
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
3
filings across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
EU GMP
0 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 31 October 2022 NAI US FDA
  • 26 September 2018 VAI US FDA
  • 30 March 2012 NAI US FDA
  • 27 September 2010 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
NORMAN, United States Not on file
Norman, United States 3004998655

Filings and GMP by regulator

Regulator Filings GMP certificates
NPRA (MY) 2 None
UZPHARM (UZ) 1 None
MFDS (Korea) None 2
ANVISA (Brazil) None 1
EAEU_EEC None 1

Questions about Avara Pharmaceutical Technologies

Does Avara Pharmaceutical Technologies hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Avara Pharmaceutical Technologies. It does have 3 filings with 2 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Avara Pharmaceutical Technologies FDA-registered?
One site operated by Avara Pharmaceutical Technologies carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Avara Pharmaceutical Technologies's last inspection go?
The most recent inspection on record closed on 31 October 2022 as NAI (No Action Indicated: nothing objectionable was found). 4 inspections are on file.
Where does Avara Pharmaceutical Technologies manufacture?
2 registered sites are on record, in United States (Norman and Norman). Every site is listed on this page with the register it came from.
Which regulators recognise Avara Pharmaceutical Technologies's GMP?
Current GMP certificates are on record from MFDS (Korea), ANVISA (Brazil) and EEC (Eurasian Economic Union). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Avara Pharmaceutical Technologies comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 31 October 2022.

Comparable suppliers

Aaa Pharmaceuticals also in United States Aarkish Pharmaceuticals NJ also in United States Abbott Laboratories also in United States Abon Pharmaceuticals also in United States Access Business Group also in United States

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates